Expanse Ice Receives FDA 510(k) Clearance for ICE Aspiration System for Peripheral Arterial, Venous Systems
Technology designed to effectively address blood clots by combining capabilities of larger devices with smaller catheters.
From Toggling Tediously Between Systems to Achieving Whole-Person Care
The rationale behind transforming case management in healthcare.
Pharma Pulse 4/22/24: Will Synthetic, AI-Based Digital Humans Change Pharma and Life Sciences? Climate Change Increases Rate of Infectious Diseases & more
The latest news for pharma industry insiders.
LogiPharma Europe 2024: Niklas Adamsson Discusses Ways to Improve Visibility and Risk Management for Cold Chain Shipping
In an interview with Pharma Commerce Editor Nicholas Saraceno, Niklas Adamsson, COO, Envirotainer, suggests how to improve visibility and risk management for cold chain shipping.
LogiPharma Europe 2024: Envirotainer COO Discusses Reshaping Cold Chain Logistics and Adapting to Disruptions
In an interview with Pharma Commerce Editor Nicholas Saraceno, Niklas Adamsson, COO, Envirotainer, offers his thoughts on how changing customer needs are affecting cold chain logistics.
FDA Approves Takeda’s Subcutaneous Form of Entyvio as a Maintenance Therapy in Adults with Moderately to Severe Crohn Disease
Approval was based on positive data from Takeda’s Phase III VISIBLE 2 study, which displayed long-term clinical remission in approximately half of patients with Crohn disease receiving Entyvio.
Pharma Pulse 4/19/24: The Real Cost of State Drug Importation Programs, Millions in Africa Will Miss HPV Shots After Merck Production Problem & more
LogiPharma Europe 2024: Properly Applying Diversity, Equity, and Inclusion Initiatives Within the Life Sciences Supply Chain
Panel discussion addresses how DE&I can successfully tackle systemic biases and more.
Genentech Shares Promising Results from Phase III OCARINA II Study of Ocrevus for Elapsing, Primary Progressive Multiple Sclerosis
Data displayed rapid and sustained B-cell depletion, with 97.2% of study patients with relapsing and primary progressive multiple sclerosis experiencing no relapses.
LogiPharma Europe 2024: Obstacles Surrounding Personalized Therapy Supply Chains
Session addresses the challenges of implementing autologous/allogeneic cell gene therapies into scalable networks.
Pharma Pulse 4/18/24: Certain Biotech Investors Get an Early Look at Results, An Ethical Outlook for Obesity Drugs & more
LogiPharma Europe 2024: Collaboration on Behalf of Sustainability
A panel uncovers the value in meeting carbon-neutral goals by 2030.
Novartis’ Fabhalta Shows Significant Promise in Reducing Proteinuria in Patients with IgA Nephropathy
Data from the Phase III APPLAUSE-IgAN study showed a 38.3% reduction in proteinuria in patients treated with Fabhalta for IgA nephropathy compared to placebo.
LogiPharma Europe 2024: A Digital Capability Transformation
Panel discussion uncovers how to alter one’s digital know-how for use in temperature-controlled supply chain.
Pharma Pulse 4/17/24: At-Home Patients and AI, Psychedelics Present Unique Ethical Challenges & more
BioHarvest Sciences Expands Operations with New 80,000 Square Foot Facility in Yavne, Israel
Company also purchased equipment for 12 good manufacturing practice clean rooms.
Evergreen Theragnostics Raises $26M in Capital to Aid Commercialization Efforts for the Ga-68 DOTATOC Diagnostic Kit
Capital also expected to assist the advancement of Evergreen's radiopharmaceutical discovery pipeline into clinical trials.
Pharma Pulse 4/16/24: Diabetes Weight Loss Drugs Could Reduce Risk of MS, Walmart Health Expands in Texas & more
Trial Findings for Minimally Invasive Parafascicular Technology Show Promise for Intracerebral Hemorrhage Treatment
Results of the trial suggest that early intervention for intracerebral hemorrhage using parafascicular surgery were safe.
Spinogenix’s Investigational New Drug Application for Novel Treatment for Fragile X Syndrome Cleared to Begin Phase II Trial
Phase IIa clinical trial of SPG60 for Fragile X syndrome offers hope for disease with no current FDA-approved treatment options.
Pharma Pulse 4/15/24: Increase in ransomware attacks to healthcare's remote access systems, The Health and Healthcare of Gen Xers & more
Does the Use of Hepatitis C Antivirals Surge Following an Easing of Medicaid Coverage Restrictions?
A difference-in-differences analysis explores the correlation between direct-acting antiviral prescriptions for hepatitis C virus and the softening of state-level limitations.
Mitigating Drug Shortages
Allen Jacques explains the history behind medications’ lack of supply, while offering ways to help alleviate their impact.
Pharma Pulse 4/12/24: The Road Ahead for GenAI-Enabled/Augmented Clinical Trials, The Health and Healthcare of Boomers & more
Evaluating the Long-Term Clinical Benefit of Cancer Treatments Granted Accelerated Approval
A cohort study digs into whether there is an improvement in overall survival or quality of life within five years of the FDA granting accelerated approval to oncology drugs.
Pharma Strategies for Succeeding Amid Strong Headwinds
Companies striving for transformed and targeted growth are exploring strategies that include partnerships, artificial intelligence, increased efficiencies, and competitive intelligence.
Pharma Pulse 4/11/24: In Battle Over Health Care Costs, Private Equity Plays Both Sides, Psychedelic Medicine Could Fill Care Gap & more
Maersk Welcomes New Facility in Sri Lanka
Wattala warehouse is expected to offer both export consolidation and 3PL services for trade routes that link Africa, Asia, and Europe.
Pharma Pulse 4/10/24: 7% of Patients with Cancer Participate in Research, Technologies Being Used to Enhance Trial Enrollment and Diversity & more
How Efficient Cold Chain Logistics Can Change the Lives of Rare Disease Patients
If manufacturers cannot ensure safe, cost-effective delivery of treatments for rare diseases, access will remain a challenges for many patients living with these conditions.
